Results 131 to 140 of about 1,259,984 (186)

Selenium deficiency causes hypertension by increasing renal AT₁ receptor expression via GPx1/H₂O₂/NF-κB pathway. [PDF]

Free Radic Biol Med, 2023
Lei L, Zhang F, Huang J, Yang X, Zhou X, Yan H, Chen C, Zheng S, Si L, Jose PA, Zeng C, Yang J.   +11 more
europepmc   +1 more source

Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor

Drug Design, Development and Therapy, 2017
Wei-Wei Zhang,1,2 Feng Bai,1 Jin Wang,1 Rong-Hua Zheng,1 Li-Wang Yang,1 Erskine A James,3 Zhi-Qing Zhao1,4 1Department of Physiology, Shanxi Medical University, 2Department of Anesthesiology, Shanxi Provincial People’s Hospital, Taiyuan, Shanxi ...
Zhang WW, Bai F, Wang J, Zheng RH, Yang LW, James EA, Zhao ZQ   +6 more
doaj  

Interation between the protooncogene mas product and the angiotensin II AT1 receptor

, 2004
1. Em vista de evidencias de que o mas proto-oncogene pode modular as respostas do receptor AT1 a angiotensina II (AngII), o objetivo deste trabalho foi avaliar, por meio de tecnicas de biologia molecular e ensaios farmacologicos, a possivel interacao ...
Santos, Edson Lucas dos [UNIFESP]
core  

Potential protective role of ACE-inhibitors and AT1 receptor blockers against levodopa-induced dyskinesias: a retrospective case-control study.

Neural Regen Res, 2021
Contaldi E, Magistrelli L, Milner AV, Cosentino M, Marino F, Comi C.   +5 more
europepmc   +1 more source

A novel interaction between soluble epoxide hydrolase and the AT1 receptor in retinal microvascular damage. [PDF]

Prostaglandins Other Lipid Mediat, 2020
Wang MH, Ibrahim AS, Hsiao G, Tawfik A, Al-Shabrawey M.   +4 more
europepmc   +1 more source

Redefining AT1 Receptor PET Imaging: Introducing the Radiotracer [¹⁸F]DR29. [PDF]

Hypertension
Chen X, Kimura H, Sasaki T, Klimek K, Mühlig S, Arias-Loza AP, Nose N, Yagi Y, Rowe SP, Lapa C, Werner RA, Higuchi T.   +11 more
europepmc   +1 more source

Activating autoantibodies against the AT1-receptor in vascular disease

, 2012
Activating autoantibodies to the angiotensin II type I receptor (AT1-AA) have been described in different vascular diseases: preeclampsia, non HLA-mediated transplantat rejection and systemic sclerosis.
Dragun, D., Riemekasten, G., Schulze-Forster, K., Mueller, D.N., Herse, F., Dechend, R., Heidecke, H.   +6 more
core  

YK-4-250, a synthetic telmisartan-tempol conjugate: crystal structure of a stabilized free radical containing an angiotensin AT₁ receptor inhibitor. [PDF]

Acta Crystallogr C Struct Chem
Friedrich S, Kong Y, Musayev FN, Brown ML, Gupton BF.   +4 more
europepmc   +1 more source

Limited AT1 Receptor Internalization Is a Novel Mechanism Underlying Sustained Vasoconstriction Induced by AT1 Receptor Autoantibody From Preeclampsia. [PDF]

J Am Heart Assoc, 2019
Bian J, Lei J, Yin X, Wang P, Wu Y, Yang X, Wang L, Zhang S, Liu H, Fu MLX.   +9 more
europepmc   +1 more source

Modulator Effect of AT1 Receptor Knockdown on THP-1 Macrophage Proinflammatory Activity. [PDF]

Biology (Basel)
Acevedo-Villavicencio LN, López-Luna CE, Castillo-Cruz J, Gutiérrez-Rojas RA, Paredes-González IS, Villafaña S, Huang F, Vargas-De-León C, Romero-Nava R, Aguayo-Cerón KA.   +9 more
europepmc   +1 more source